A Ph1b/2 Study of Axatilimab Monotherapy in Chinese Participants With Recurrent or Refractory cGVHD
Clinical trial NCT06843408 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06843408
- Sponsor
- Incyte Corporation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-25
- Primary completion
- 2027-01-06
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.